Related Experiment Videos
Bioactive phenolics from Carthamus lanatus L.
Rilka Taskova1, Maya Mitova, Bozhanka Mikhova
1Institute of Botany, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Zeitschrift Fur Naturforschung. C, Journal of Biosciences
|October 28, 2003
Summary
This study identified novel compounds in Carthamus lanatus, including isorhamnetin 3-O-beta-D-glucoside and chlorogenic acid. The ethyl acetate fraction showed significant antioxidant activity, with luteolin 7-O-beta-D-glucoside being the main constituent.
Area of Science:
- Phytochemistry
- Pharmacognosy
- Natural Product Chemistry
Background:
- Carthamus lanatus, a plant species, is a potential source of bioactive compounds.
- Flavonoids and phenolic acids are known for their diverse biological activities.
Purpose of the Study:
- To isolate and identify chemical constituents from the aerial parts of Carthamus lanatus.
- To evaluate the antioxidant and cytotoxic activities of the isolated compounds and plant extracts.
Main Methods:
- Phytochemical analysis involving isolation techniques for flavonoids and phenolic acids.
- In vitro antioxidant activity assessment using the alpha,alpha-diphenyl-beta-picrazylhydrazyl (DPPH) free radical scavenging assay.
- Cytotoxicity evaluation of the primary isolated compound.
Main Results:
- Isolation of two flavonoid aglycons, eight flavonoid glycosides, chlorogenic acid, and syringin.
- Identification of isorhamnetin 3-O-beta-D-glucoside and chlorogenic acid as new compounds for the genus Carthamus.
- The ethyl acetate fraction demonstrated superior antioxidant capacity compared to the butanol fraction.
- Luteolin 7-O-beta-D-glucoside was identified as the main constituent with evaluated cytotoxicity and antioxidant properties.
Conclusions:
- The phytochemical investigation of Carthamus lanatus yielded a diverse range of flavonoid glycosides and phenolic compounds.
- The plant extract exhibits significant antioxidant potential, primarily attributed to its ethyl acetate fraction.
- Further research into luteolin 7-O-beta-D-glucoside may reveal therapeutic applications.